143 related articles for article (PubMed ID: 37490266)
21. Prognostic evaluation of patients with multicentric papillary thyroid microcarcinoma.
Kuo SF; Chao TC; Chang HY; Hsueh C; Yang CH; Lin JD
J Formos Med Assoc; 2011 Aug; 110(8):511-7. PubMed ID: 21783020
[TBL] [Abstract][Full Text] [Related]
22. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.
Sung TY; Lee YM; Yoon JH; Chung KW; Hong SJ
World J Surg; 2015 Aug; 39(8):1930-5. PubMed ID: 25894401
[TBL] [Abstract][Full Text] [Related]
23. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
[TBL] [Abstract][Full Text] [Related]
24. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
[TBL] [Abstract][Full Text] [Related]
25. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.
Soydal C; Araz M; Ozkan E; Arslantaş E; Kucuk ON; Aras G
Nucl Med Commun; 2015 Feb; 36(2):109-13. PubMed ID: 25321158
[TBL] [Abstract][Full Text] [Related]
26. [The course of differentiated thyroid microcarcinoma in patients treated by different therapeutic strategies].
Grigerová M; Griger M; Mojtová E; Podoba J
Vnitr Lek; 2016; 62(9 Suppl 3):17-21. PubMed ID: 27734686
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of surgical treatment of papillary thyroid carcinoma].
Zhang ZM; Li ZJ; Tang PZ; Xu ZG; An CM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):779-82. PubMed ID: 22335912
[TBL] [Abstract][Full Text] [Related]
30. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
31. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
32. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
33. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
Yan L; Zhang M; Song Q; Luo Y
Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
[No Abstract] [Full Text] [Related]
35. Prognostic factors in patients with papillary thyroid carcinoma.
Soyluk O; Selcukbiricik F; Erbil Y; Bozbora A; Kapran Y; Ozbey N
J Endocrinol Invest; 2008 Nov; 31(11):1032-7. PubMed ID: 19169062
[TBL] [Abstract][Full Text] [Related]
36. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.
Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS
Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159
[TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography.
Lee HS; Park HS; Kim SW; Choi G; Park HS; Hong JC; Lee SG; Baek SM; Lee KD
Eur Arch Otorhinolaryngol; 2013 Nov; 270(11):2969-74. PubMed ID: 23873032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]